journal article·2018-09

Anti-inflammatory polymersomes of redox-responsive polyprodrug amphiphiles with inflammation-triggered indomethacin release characteristics

Jiajia Tan, Zhengyu Deng, Guhuan Liu, Jinming Hu, Shiyong Liu

Biomaterials· Volume 178
Publisher page

Abstract

Inflammation serves as a natural defense mechanism to protect living organisms from infectious diseases. Nonsteroidal anti-inflammatory drugs (NSAIDs) can help relieve inflammatory reactions and are clinically used to treat pain, fever, and inflammation, whereas long-term use of NSAIDs may lead to severe side effects including gastrointestinal damage and cardiovascular toxicity. Therefore, it is of increasing importance to configure new dosing strategies and alleviate the side effects of NSAIDs. Towards this goal, glutathione (GSH)-responsive disulfide bonds and hydrogen peroxide (H2O2)-reactive phenylboronic ester linkages were utilized as triggering moieties in this work to design redox-responsive prodrug monomers and polyprodrug amphiphiles based on indomethacin (IND) drug. Note that IND is a widely prescribed NSAID in the clinic. Starting from three types of redox-reactive IND prodrug monomers, redox-responsive polyprodrug amphiphiles were synthesized through reversible addition-fragmentation chain transfer (RAFT) polymerizations of prodrug monomers using poly(ethylene oxide) (PEO)-based macroRAFT agent. The resultant polyprodrug amphiphiles with high IND loading contents (>33 wt%) could self-assemble into polymersomes with PEO shielding coronas and redox-responsive bilayer membranes composed of IND prodrugs. Upon incubation with GSH or H2O2, controlled release of intact IND in the active form from polyprodrug polymersomes was actuated by GSH-mediated disulfide cleavage reaction and H2O2-mediated oxidation of phenylboronic ester moieties, respectively, followed by self-immolative degradation events. Furthermore, in vitro studies at the cellular level revealed that redox-responsive polymersomes could efficiently relieve inflammatory responses induced by lipopolysaccharide (LPS) in RAW264.7 macrophage cells.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Polymer Synthesis and Characterization · Dendrimers and Hyperbranched Polymers · Antimicrobial agents and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (70)

Show source-provided references
1. Homeostasis, inflammation, and disease susceptibility10.1016/j.cell.2015.02.010 ↗
2. Clinical relevance of drug interactions between nonsteroidal antiinflammatory drugs (NSAIDs) and antihypertensives10.1016/j.aprim.2013.11.010 ↗
3. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries10.1371/journal.pmed.1001388 ↗
4. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice10.1186/1471-2474-7-79 ↗
5. Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review10.3390/ijms131217244 ↗
6. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review10.1016/S0168-3659(99)00248-5 ↗
7. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect10.1016/j.addr.2010.04.009 ↗
8. Preparation and antibacterial mechanism insight of polypeptide-based micelles with excellent antibacterial activities10.1021/acs.biomac.6b01285 ↗
9. Antibacterial polypeptide-grafted chitosan-based nanocapsules as an "armed" Carrier of anticancer and antiepileptic drugs10.1021/mz400480z ↗
10. Development of macromolecular prodrug for rheumatoid arthritis10.1016/j.addr.2012.03.006 ↗
11. Liposomes as carriers for anti-inflammatory agents10.1016/0169-409X(89)90028-8 ↗
12. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles10.1021/js950204r ↗
13. Specific interactions improve the loading capacity of block copolymer micelles in aqueous media10.1021/la700337s ↗
14. Nanocontainers formed by self-assembly of poly(ethylene oxide)-b-poly(glycerol monomethacrylate) - drug conjugates10.1021/ma062562u ↗
15. Preparation of well-defined ibuprofen prodrug micelles by RAFT polymerization10.1021/bm4009149 ↗
16. Well-defined podophyllotoxin polyprodrug brushes: preparation via RAFT polymerization and evaluation as drug carriers10.1039/C6PY01883A ↗
17. Esterase-activated release of naproxen from supramolecular nanofibres10.1039/C4CC06340F ↗
18. Full-course inhibition of biodegradation-induced inflammation in fibrous scaffold by loading enzyme-sensitive prodrug10.1016/j.biomaterials.2015.02.078 ↗
19. pH-Responsive nanoparticles based on ibuprofen prodrug as drug carriers for inhibition of primary tumor growth and metastasis10.1039/C7TB01288H ↗
20. Nanoparticles with dual responses to oxidative stress and reduced pH for drug release and anti-inflammatory applications10.1021/nn4058787 ↗
21. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells10.1124/jpet.103.056622 ↗
22. Eicosanoids and cancer10.1038/nrc2809 ↗
23. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappa B10.1002/ijc.22570 ↗
24. Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression10.1007/s10565-016-9351-z ↗
25. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery10.1016/j.biomaterials.2013.01.084 ↗
26. Controlled release of an anti-inflammatory drug using an ultrasensitive ROS-responsive gas-generating carrier for localized inflammation inhibition10.1021/jacs.5b08057 ↗
27. Cell-penetrating hyperbranched polyprodrug amphiphiles for synergistic reductive milieu-triggered drug release and enhanced magnetic resonance signals10.1021/ja5105848 ↗
28. Stimuli-responsive nanomedicines for overcoming cancer multidrug resistance10.7150/thno.22679 ↗
29. Curcumin polymers as anticancer conjugates10.1016/j.biomaterials.2010.06.007 ↗
30. Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery10.1016/j.biomaterials.2011.08.022 ↗
31. Smart and hyper-fast responsive polyprodrug nanoplatform for targeted cancer therapy10.1016/j.biomaterials.2015.10.056 ↗
32. Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery10.1021/ja409686x ↗
33. Bioapplications of RAFT polymerization10.1021/cr9001403 ↗
34. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities10.1016/S0169-409X(02)00179-5 ↗
35. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin10.1016/j.biomaterials.2009.07.051 ↗
36. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery10.1016/j.jconrel.2011.01.030 ↗
37. ROS-responsive polyprodrug nanoparticles for triggered drug delivery and effective cancer therapy10.1002/adma.201700141 ↗
38. Molecular design and synthesis of self-assembling camptothecin drug amphiphiles10.1038/aps.2016.151 ↗
39. Supramolecular nanostructures formed by anticancer drug assembly10.1021/ja3115983 ↗
40. Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems10.1021/ar200126t ↗
41. An activatable prodrug for the treatment of metastatic tumors10.1021/ja5077684 ↗
42. A unique paradigm for a turn-ON near-infrared cyanine-based probe: noninvasive intravital optical imaging of hydrogen peroxide10.1021/ja203145v ↗
43. Engineering intracellular delivery nanocarriers and nanoreactors from oxidation-responsive polymersomes via synchronized bilayer cross-linking and permeabilizing inside live cells10.1021/jacs.6b04115 ↗
44. H2O2-responsive vesicles integrated with transcutaneous patches for glucose-mediated insulin delivery10.1021/acsnano.6b06892 ↗
45. Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide10.1021/ja303372u ↗
46. Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery10.1021/acs.nanolett.6b03848 ↗
47. Leveraging H2O2 levels for biomedical applications10.1002/adbi.201700084 ↗
48. Polymerization-induced self-assembly of galactose-functionalized biocompatible diblock copolymers for intracellular delivery10.1021/ja407033x ↗
49. 1,9-dithia[2.2]paracyclophane: synthesis, molecular structure, and properties10.1021/jo951426c ↗
50. Sugar-breathing glycopolymersomes for regulating glucose level10.1021/jacs.7b03219 ↗
51. Polymer vesicles: mechanism, preparation, application, and responsive behavior10.1016/j.progpolymsci.2015.05.001 ↗
52. Polymer vesicles: modular platforms for cancer theranostics
53. Self-assembled block copolymer aggregates: from micelles to vesicles and their biological applications10.1002/marc.200800713 ↗
54. Self-assembly of block copolymers10.1039/c2cs35115c ↗
55. Polymersomes for drug delivery: design, formation and characterization10.1016/j.jconrel.2011.10.005 ↗
56. Stimuli-responsive polymersomes for programmed drug delivery10.1021/bm801127d ↗
57. Intracellular delivery of chemical probes using a glutathione-responsive traceless tag10.1039/C6CC03336A ↗
58. Self-immolative linkers literally bridge disulfide chemistry and the realm of thiol-free drugs10.1002/adhm.201500344 ↗
59. Mutual prodrugs containing bio-cleavable and drug releasable disulfide linkers10.1016/j.bioorg.2013.06.007 ↗
60. Tuning of hydrogen peroxide-responsive polymeric micelles of biodegradable triblock polycarbonates as a potential drug delivery platform with ratiometric fluorescence signaling10.1039/C5PY01557J ↗
61. A biocompatible oxidation-triggered Carrier polymer with potential in therapeutics10.1021/ja110468v ↗
62. A general strategy to construct fluorogenic probes from charge-generation polymers (CGPs) and AIE-active fluorogens through triggered complexation10.1002/anie.201105735 ↗
63. Stimuli-triggered off/on switchable complexation between a novel type of charge-generation polymer (CGP) and gold nanoparticles for the sensitive colorimetric detection of hydrogen peroxide and glucose10.1021/ma102608a ↗
64. Glutathione responsive polymers and their application in drug delivery systems10.1039/C6PY01365A ↗
65. Oxidation-accelerated hydrolysis of the ortho ester-containing acid-labile polymers10.1021/mz4000392 ↗
66. Modulated fragmentation of proapoptotic peptide nanoparticles regulates cytotoxicity10.1021/jacs.6b11302 ↗
67. New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine10.1021/bc990031n ↗
68. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality10.1080/07853890310017053 ↗
69. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics10.1038/nrc1801 ↗
70. In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles10.1038/nmat1983 ↗